Elekta AB (publ)

BATS-CHIXE:EKTABS Stock Report

Market Cap: SEK 22.2b

Elekta Valuation

Is EKTABS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EKTABS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

SEK 107.71
Fair Value
45.7% undervalued intrinsic discount
13
Number of Analysts

Below Fair Value: EKTABS (SEK58.53) is trading below our estimate of fair value (SEK107.71)

Significantly Below Fair Value: EKTABS is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EKTABS?

Key metric: As EKTABS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EKTABS. This is calculated by dividing EKTABS's market cap by their current earnings.
What is EKTABS's PE Ratio?
PE Ratio75.9x
EarningsSEK 292.00m
Market CapSEK 22.16b

Price to Earnings Ratio vs Peers

How does EKTABS's PE Ratio compare to its peers?

The above table shows the PE ratio for EKTABS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.2x
SN. Smith & Nephew
28.7x15.17%UK£10.6b
NIOX NIOX Group
60.9x34.15%UK£298.4m
EKF EKF Diagnostics Holdings
17.3xn/aUK£105.6m
AOTI AOTI
21.8x72.36%UK£38.8m
EKTABS Elekta
75.9x28.58%SEK 22.2b

Price-To-Earnings vs Peers: EKTABS is expensive based on its Price-To-Earnings Ratio (75.9x) compared to the peer average (32.2x).

Price to Earnings Ratio vs Industry

How does EKTABS's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies15PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EKTABS is expensive based on its Price-To-Earnings Ratio (75.9x) compared to the European Medical Equipment industry average (27.2x).

Price to Earnings Ratio vs Fair Ratio

What is EKTABS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EKTABS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio75.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EKTABS's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EKTABS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 58.53
SEK 55.77
-4.71%
31.28%SEK 108.00SEK 34.00n/a13
Nov ’26n/a
SEK 53.60
0%
31.80%SEK 108.00SEK 34.00n/a13
Oct ’26SEK 47.13
SEK 53.69
+13.92%
31.69%SEK 108.00SEK 34.00n/a13
Sep ’26SEK 47.25
SEK 55.31
+17.05%
28.99%SEK 108.00SEK 39.00n/a13
Aug ’26n/a
SEK 58.58
0%
27.38%SEK 108.00SEK 39.00n/a13
Jul ’26SEK 48.80
SEK 58.58
+20.03%
27.38%SEK 108.00SEK 39.00n/a13
Jun ’26SEK 50.20
SEK 62.15
+23.81%
23.83%SEK 108.00SEK 47.00n/a13
May ’26SEK 49.17
SEK 67.07
+36.41%
21.04%SEK 108.00SEK 51.50n/a14
Apr ’26n/a
SEK 67.07
0%
21.04%SEK 108.00SEK 51.50n/a14
Mar ’26n/a
SEK 69.86
0%
27.36%SEK 127.00SEK 51.50n/a14
Feb ’26n/a
SEK 73.31
0%
26.54%SEK 127.00SEK 51.50n/a13
Jan ’26n/a
SEK 73.38
0%
27.12%SEK 127.00SEK 51.50n/a13
Dec ’25n/a
SEK 74.12
0%
25.95%SEK 127.00SEK 57.00n/a13
Nov ’25n/a
SEK 76.36
0%
23.64%SEK 127.00SEK 57.00n/a14
Oct ’25SEK 72.25
SEK 76.21
+5.49%
23.82%SEK 127.00SEK 57.00SEK 47.1314
Sep ’25SEK 70.35
SEK 76.69
+9.02%
24.66%SEK 127.00SEK 57.00SEK 47.2513
Aug ’25SEK 66.55
SEK 76.31
+14.66%
24.95%SEK 127.00SEK 57.00n/a13
Jul ’25SEK 66.18
SEK 76.38
+15.43%
24.74%SEK 127.00SEK 57.00SEK 48.8013
Jun ’25SEK 87.45
SEK 84.08
-3.85%
24.36%SEK 127.00SEK 57.00SEK 50.2012
May ’25n/a
SEK 83.42
0%
24.47%SEK 127.00SEK 57.00SEK 49.1712
Apr ’25n/a
SEK 86.00
0%
23.69%SEK 127.00SEK 57.00n/a12
Mar ’25n/a
SEK 86.33
0%
23.35%SEK 127.00SEK 57.00n/a12
Feb ’25n/a
SEK 86.67
0%
23.42%SEK 127.00SEK 57.00n/a12
Jan ’25n/a
SEK 84.73
0%
23.30%SEK 127.00SEK 57.00n/a11
Dec ’24n/a
SEK 84.91
0%
23.73%SEK 127.00SEK 57.00n/a11
Nov ’24SEK 75.87
SEK 82.00
+8.08%
26.19%SEK 127.00SEK 53.00n/a11
SEK 56.27
Fair Value
4.0% overvalued intrinsic discount
13
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/30 15:31
End of Day Share Price 2025/11/27 00:00
Earnings2025/10/31
Annual Earnings2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elekta AB (publ) is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Alexander KlebanBarclays
Sally TaylorBarclays